Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
BMC Pregnancy and Childbirth
|
November 20, 2024
Impact of varied feeding protocols on gastrointestinal function recovery in the early postoperative period following repeat cesarean section: a randomized controlled trial
Xiao-Li Hu, Yu-Peng Wang, Lu-Ping Wu, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
April 7, 2020
Upregulation of miR-219a-5p Decreases Cerebral Ischemia/Reperfusion Injury In Vitro by Targeting Pde4d
Min-Yi Lu, Jin-Rong Wu, Rui-Bing Liang, et al.
Zhonghua Yi Xue Za Zhi
|
January 19, 2013
[Expression of neuropilin 2 in human colorectal carcinoma and its correlation with lymphangiogenesis and lymphatic metastasis of tumor]
Wei-guo Xu, Yu-peng Wang, Zhi-yi Guo, et al.
Frontiers in Immunology
|
March 13, 2023
Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapy
De-Zhen Guo, Shi-Yu Zhang, San-Yuan Dong, et al.
Annals of Translational Medicine
|
November 17, 2022
Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria
De-Zhen Guo, Jian-Wen Cheng, Jia-Yan Yan, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
|
June 29, 2023
[Systematic review and Meta-analysis of Gusongbao preparation in treatment of primary osteoporosis]
Jie-Hang Lu, Zheng-Yan Li, Guo-Qing DU, et al.
Frontiers in Oncology
|
March 13, 2023
Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy
De-Zhen Guo, Shi-Yu Zhang, San-Yuan Dong, et al.
Annals of Translational Medicine
|
July 16, 2021
A novel preoperative predictive model of 90-day mortality after liver resection for huge hepatocellular carcinoma
Yue Yin, Jian-Wen Cheng, Fei-Yu Chen, et al.
Frontiers in Oncology
|
June 27, 2022
Integration of Inflammation-Immune Factors to Build Prognostic Model Predictive of Prognosis and Minimal Residual Disease for Hepatocellular Carcinoma
Xin Xu, Ao Huang, De-Zhen Guo, et al.
Cellular & Molecular Immunology
|
April 20, 2018
Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects
Kai-Yang Tang, Jason Lickliter, Zhi-Hua Huang, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
BMC Pregnancy and Childbirth
|
November 20, 2024
Impact of varied feeding protocols on gastrointestinal function recovery in the early postoperative period following repeat cesarean section: a randomized controlled trial
Xiao-Li Hu, Yu-Peng Wang, Lu-Ping Wu, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
April 7, 2020
Upregulation of miR-219a-5p Decreases Cerebral Ischemia/Reperfusion Injury In Vitro by Targeting Pde4d
Min-Yi Lu, Jin-Rong Wu, Rui-Bing Liang, et al.
Zhonghua Yi Xue Za Zhi
|
January 19, 2013
[Expression of neuropilin 2 in human colorectal carcinoma and its correlation with lymphangiogenesis and lymphatic metastasis of tumor]
Wei-guo Xu, Yu-peng Wang, Zhi-yi Guo, et al.
Frontiers in Immunology
|
March 13, 2023
Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapy
De-Zhen Guo, Shi-Yu Zhang, San-Yuan Dong, et al.
Annals of Translational Medicine
|
November 17, 2022
Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria
De-Zhen Guo, Jian-Wen Cheng, Jia-Yan Yan, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
|
June 29, 2023
[Systematic review and Meta-analysis of Gusongbao preparation in treatment of primary osteoporosis]
Jie-Hang Lu, Zheng-Yan Li, Guo-Qing DU, et al.
Frontiers in Oncology
|
March 13, 2023
Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy
De-Zhen Guo, Shi-Yu Zhang, San-Yuan Dong, et al.
Annals of Translational Medicine
|
July 16, 2021
A novel preoperative predictive model of 90-day mortality after liver resection for huge hepatocellular carcinoma
Yue Yin, Jian-Wen Cheng, Fei-Yu Chen, et al.
Frontiers in Oncology
|
June 27, 2022
Integration of Inflammation-Immune Factors to Build Prognostic Model Predictive of Prognosis and Minimal Residual Disease for Hepatocellular Carcinoma
Xin Xu, Ao Huang, De-Zhen Guo, et al.
Cellular & Molecular Immunology
|
April 20, 2018
Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects
Kai-Yang Tang, Jason Lickliter, Zhi-Hua Huang, et al.
Page
of 5